Biblio
Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease. Blood Adv. 2020;4(16):3894-3899.
. The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities. Transplant Cell Ther. 2024.
Granulocyte Colony-Stimulating Factor is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2021.
Immune Reconstitution and Infection Patterns Following Early Alemtuzumab and Reduced Intensity Transplantation for Non-Malignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2018.
Impact of Hospital Acquired Infections on Post-Transplant One Year Mortality in Pediatric Bone Marrow Transplant Patients. Am J Infect Control. 2020.
. Pediatric vulvovaginal graft-versus-host disease: A retrospective cohort study and literature review. J Pediatr Adolesc Gynecol. 2022.
. .